HOME › DRUGS › AFICAMTEN
ACTIVE SUBSTANCE / INN

AFICAMTEN

Brand name(s): MYQORZO, Myqorzo
FDA LISTED
EMA LISTED
PRESCRIPTION
AUTHORISED
Cardiomyopathy, Hypertrophic
NDA219083
ACTIVE SUBSTANCE
Aficamten
REGULATORS
FDA · EMA
SPONSORS / MAH
CYTOKINETICS, Cytokinetics (Ireland) Limited
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
MYQORZONDA219083CYTOKINETICSPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
MyqorzoCytokinetics (Ireland) LimitedAuthorised12/02/2026Cardiomyopathy, Hypertrophic

FULL INTELLIGENCE ON AFICAMTEN

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →